To include your compound in the COVID-19 Resource Center, submit it here.

ANAVEX 2-73: Phase I ongoing

Anavex said a Safety Review Committee approved advancing to the 30

Read the full 113 word article

Trial Subscription

Get a two-week free trial subscription to BioCentury

SIGN UP

Article Purchase

This article may not be distributed to non-subscribers
More Info >PURCHASE